Your email has been successfully added to our mailing list.

×
-0.0373443983402491 -0.0373443983402491 -0.0373443983402491 -0.0373443983402491 -0.0373443983402491 -0.00414937759336109 -0.00414937759336109 -0.00414937759336109
Stock impact report

TScan Therapeutics Taps Jason A. Amello as Finance Chief [MarketWatch]

Candel Therapeutics, Inc. (CADL) 
Company Research Source: MarketWatch
Amello was formerly the finance chief of Candel Therapeutics and held similar positions at other pharmaceutical companies. Advertisement TScan's former CFO, Brian Silver, left the clinical-stage biopharmaceutical company in July. Write to Mary de Wet at mary.dewet@dowjones.com Show less Read more
Impact Snapshot
Event Time:
CADL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CADL alerts
Opt-in for
CADL alerts

from News Quantified
Opt-in for
CADL alerts

from News Quantified